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Abstract: Substantial progress has been made in identifying single genetic variants predispos-
ing to common complex diseases. Nonetheless, the genetic etiology of human diseases remains
largely unknown. Human complex diseases are likely influenced by the joint effect of a large
number of genetic variants instead of a single variant. The joint analysis of multiple genetic
variants considering linkage disequilibrium (LD) and potential interactions can further enhance
the discovery process, leading to the identification of new disease-susceptibility genetic vari-
ants. Motivated by development in spatial statistics, we propose a new statistical model based
on the random field theory, referred to as a genetic random field model (GenRF), for joint
association analysis with the consideration of possible gene-gene interactions and LD. Using a
pseudo-likelihood approach, a GenRF test for the joint association of multiple genetic variants
is developed, which has the following advantages: 1. accommodating complex interactions for
improved performance; 2. natural dimension reduction; 3. boosting power in the presence of
LD; 4. computationally efficient. Simulation studies are conducted under various scenarios.
The development has been focused on quantitative traits and robustness of the GenRF test
to other traits, e.g., binary traits, is also discussed. Compared with a commonly adopted ker-
nel machine approach, SKAT, as well as other more standard methods, GenRF shows overall
comparable performance and better performance in the presence of complex interactions. The
method is further illustrated by an application to the Dallas Heart Study.
Keywords and phrases: Complex interaction; Genetic association; Linkage disequilibrium;
Multi-marker test; Pseudo-likelihood; Random field..
1. Introduction
With the advance of high-throughput technologies, high-dimensional genetic data have been widely
used in association studies for the identification of genetic variants contributing to common complex
diseases. While a large number of genetic variants have been revealed today to be individually
associated with complex diseases, they only explain a small proportion of heritability (Manolio, et al.,
∗This paper has been published on Biometrics
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2009). Complex diseases are likely influenced by the joint effect of genetic variants through complex
biology pathways, given the fact that genes are the functional sets. However, the multiple testing
problem occurs when one considers a set of single locus analyses, which dramatically diminishes
power. Therefore, the joint analysis of a functional set of genetic variants simultaneously can further
enhance the discovery process, leading to the identification of new genetic variants associated with
complex diseases (Chatterjee, et al. 2006). While the conventional linear or logistic regression models
can easily be used for joint association analyses, they are subject to several issues, such as multiple-
collinearity, when dealing with a large ensemble of dense genetic markers. The exponentially increased
number of parameters also makes them impractical to model two-way or high-order interactions
among a large number of genetic variants (Ritchie, et al., 2001).
Several new statistical methods have been recently developed for joint association analysis, includ-
ing the kernel machine based method (well known as SKAT)(Wu, et al., 2010; Wu, et al. 2011) and
the similarity regression (SIMreg) (Tzeng, et al. 2009). Both methods significantly reduce the number
of regression parameters, making it feasible and computationally efficient to handle high-dimensional
variants. In addition, they account for linkage disequilibrium (LD) and potential interactions, which
further improve performance. Both SKAT and SIMreg can be thought of as being developed from
the general idea that, if genetic association exists, then genetic similarity leads to trait similarity,
which is also the intuition behind our method.
In this paper, we propose a random field framework for modeling and testing for the joint asso-
ciation of multiple genetic variants. We view outcomes as stochastic realizations of a random field
on a genetic space and propose to use a random field model, referred to as a genetic random field
model (GenRF), to model the joint association. This approach is motivated by development in spa-
tial statistics where outcomes are viewed as stochastic realizations of a random field on a Euclidean
space (Cressie, 1993). This perspective leads to a very distinctive model from the aforementioned
methods; specifically, GenRF regresses the response of one subject on responses of all other subjects.
GenRF can be understood from the intuition that genetic similarity leads to trait similarity if vari-
ants are associated with the trait. Under the GenRF model, testing for the joint association reduces
to a test involving a scalar parameter. Using the pseudo-likelihood method, a test for the joint asso-
ciation is developed, which enjoys many appealing features as SKAT and can achieve comparable or
better performance than existing methods, as demonstrated by simulation studies in Section 3 and
a real data application in Section 4. Much of the development is focused on quantitative traits and
robustness of the test to other traits, e.g., binary traits, is also discussed.
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There is a long history of applying spatial statistical methods to the analysis of genetic data
(e.g., Thomas, et al., 2003; Molitor, et al., 2003a; Molitor, et al., 2003b; Iorio and Verzilli, 2007).
For example, Iorio and Verzilli (2007) used a spatial probit model to account for the local spatial
correlation between variants physically close for fine-scale mapping of disease genes. Molitor, et al.
(2003b) used spatial clustering techniques for fine-scale gene mapping. Probably the most closely
related work to ours is Molitor, et al. (2003a), which used a spatial auto-regressive model for analysis
of haplotypes effects and gene mapping. It differs from our work in two ways. First, it is haplotype-
based whereas ours is genotype-based. Second, it is developed from the Bayesian framework where
the trait is related to haplotypes through a linear model and the spatial model is used to model
the prior distribution of haplotype effects, whereas our method directly models traits using a spatial
model via a frequentist approach. In this paper, we focus on multi-marker association testing and
the direct spatial modeling of traits using a frequentist approach leads to a test that is analytically
tractable and easy to implement.
2. Method
2.1. Genetic Random Field Model
Consider a study where n subjects are sequenced in a region of interest. For subject i, i = 1, . . . , n,
letGi denote the genotype for the p variants within the region, Yi the trait or phenotype, andXi the
other covariates including, for example, demographic and environmental factors. We are interested
in studying the joint association between variants Gi and trait Yi, possibly adjusted for the effect
of Xi.
As SKAT and SIMreg, our method is also motivated by the general idea that, if the genetic
variants are jointly associated with a trait, then the genetic similarity across subjects will contribute
to the trait similarity. To put it in another way, if variants are jointly associated with the trait, then
the response of a subject would be close to the response of other subjects who share similar genetic
and possibly other variables. Based on this key idea, we propose to directly model the response of
each subject as a function of all other responses and the contribution of other responses to Yi is
weighted by their genetic similarity.
For simplicity, we temporarily assume Yi’s are centered (have mean zero) and there are no other
adjustment covariates. Specifically, based on the idea discussed above, we model the conditional
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distribution of Yi given all other responses as
Yi|Y −i ∼ γ
∑
j 6=i
s(Gi,Gj)Yj + εi, (1)
where Y −i denotes responses for all other subjects except Yi ; s(Gi,Gj) is known weights, weighting
the contribution of Yj on approximating (or predicting) Yi via their genetic similarity; γ is a non-
negative coefficient measuring the magnitude of the overall contribution, further discussed below;
and εi’s are random errors. A proper weight function s(Gi,Gj) gives higher value when the two
subjects are more similar in terms of genetic variants and, as discussed below, can be viewed as a
measure for proximity of two subjects in a genetic space. The random errors εi’s are assumed to
be independent and identically distributed with Normal(0, ζ2); extension to distributions other than
normal is discussed in Section 2.2.
A main distinction between model (1) and the usual regression is that (1) models the conditional
distribution of Yi given traits of other subjects, whereas in the usual regression one models the
conditional distribution of a subject’s traits given his/her genetic variants. Intuitively, model (1)
states that the trait of a subject can be approximated by traits of other subjects who are similar in
genetic variants, if variants are associated with the trait. The coefficient γ indicates the magnitude
of the trait similarity as a result of genetic similarity. Thus, γ can also be interpreted as a measure
for the magnitude of the joint association of Gi with Yi. Specifically, if Gi is not associated with Yi,
then regardless of how similar subject i is to other subjects in terms of their genetic variants, the
trait Yi is independent of all other Yj ’s for j 6= i; that is, γ = 0. On the contrary, if Gi is strongly
associated with Yi, then one may expect Yi can largely be predicted by traits of subjects having the
same or similar genetic variants and a large γ indicates a strong joint association. Therefore, we can
test the joint association of genetic variants with the trait by testing a null hypothesis involving a
single parameter, i.e., H0 : γ = 0.
Models like (1), where responses are regressed on responses themselves, are referred as auto-
regressive models and are commonly used in spatial statistics. In this article, we view the trait as
a random field on a genetic space, and from this perspective, model (1) is formally a conditional
auto-regressive (CAR) model (Cressie, 1993). A random field is a generalization of the notation of
a stochastic process (Adler and Taylor, 2007). Informally, a stochastic process is a set of random
variables indexed by integers or real numbers. A random field can be defined in more general spaces
with the index set being an Euclidean space of dimension greater than one or other spaces. For
example, in spatial statistics, crop yields of regions can be viewed as a random field defined in a
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two-dimensional space. Regions that are closer in location have more similar crop yields if spatial
correlation exists. For our problem, we may view observed traits as realizations of a random field
defined in a p-dimensional space of the p genetic variants; that is, corresponding to each “location”
in the p-dimensional genetic space, there is a random response variable associated with it. Similarly,
responses from locations that are “closer” in the genetic space are expected to be more similar if
the genetic association exists. In this sense, our model is a generalization of the auto-regressive
model in spatial statistics. Models like (1) were firstly studied in the seminar work of Besag (1974)
for random fields and we will term our model (1) as a genetic random field (GenRF) model. As
a matter of fact, the GenRF model is closely related to the CAR model in spatial statistics; that
is s(Gi,Gj) analogously defines the proximity of neighbor Gj to Gi and γ is the counterpart of
a spatial dependence parameter. However, we note that the usual tests of spatial dependence, for
example, the Cliff-Ord-test (Cliff and Ord, 1972) and the Lagrange Multiplier test (Burridge, 1980),
do not apply in our setting to test for the joint association of variants. The reason is that the matrix
S, defined below, in our GenRF model does not satisfy the regularity condition usually assumed in
spatial statistics for deriving the asymptotic distribution, as each subject has infinite neighbors in
the genetic space.
We have yet to define a measure for “closeness” in the genetic space. Suppose each component of
Gi records the number of minor alleles in a single locus and takes on values {0, 1, 2}, respectively,
corresponding to {AA,Aa, aa}. Then a sensible measure for closeness or similarity is the so called
identity-by-state (IBS) (Wu, et al., 2010), defined as
s(Gi,Gj) =
p∑
k=1
{2− |Gik −Gjk|}.
That is, the IBS measures the number of alleles in the region of interest shared by two individuals;
for example, for p = 1, s(AA,AA) = 2, s(Aa, aa) = 1, s(AA, aa) = 0. Other measures for closeness
in the genetic space rather than IBS are also possible, e.g., the other kernel functions discussed in
Wu, at al. (2010), providing flexibility in our GenRF model. Similar to SKAT, our GenRF model
can also incorporate weights to increase the importance of rare variants. Specifically, one can define
s(Gi,Gj) =
∑p
k=1 wk{2− |Gik −Gjk|}, where wk is a prespecified weight for variant k; see Wu, et
al., (2011) for more discussions on wk.
So far we have focused on the situation where no covariate adjustment is required. If adjustment
for other factors is needed a natural extension of model (1) is given by
Yi|Y −i,Xi ∼ β
TXi + γ
∑
j 6=i
s(Gi,Gj)(Yj − β
TXj) + εi. (2)
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An intercept term is included in Xi and, as a result, in (2) Yi’s are not required to be centered.
Under this model, testing for the joint association of Gi with Yi after adjusting for other factors is
also equivalent to testing H0 : γ = 0. We will mainly focus on this more general form of the GenRF
model in the development of a testing procedure. For simplicity, the matrix form of the GenRF
model is given by
Y |Y −,X =Xβ + γS(Y −Xβ) + ε, (3)
where Y is (Y1, . . . , Yn)
T ; Y − is (Y −1, . . . ,Y −n)
T ;X is an n×q matrix defined as (XT1 , . . . ,X
T
n )
T ;
ε ∼ Normal (0, ζ2In×n); and S is an n × n symmetric matrix with zeros on the diagonal and the
(i, j)-th element s(Gi,Gj) for i 6= j.
According to the factorization theorem of Besag (1974), our GenRF model in (2) uniquely deter-
mines the following joint distribution of Y , i.e.,
Y |X ∼Xβ + v, v ∼ N(0, ζ2(I − γS)−1), (4)
where v is an n-dimensional random column vector. Note, the coefficient γ used for describing the
conditional expectation of Yi given others in model (1) actually describes the correlations among
Yi’s. It is clear that, under the null hypothesis that there is no association between Gi and Yi, i.e.,
γ = 0, Yi’s are uncorrelated, but if γ > 0, GenRF states that Yi’s are positively correlated as a result
of having similar genetic variants associated with the trait.
2.2. Genetic Random Field Test
In this subsection, we focus on developing a test for the null hypothesis H0 : γ = 0 based on model
(2). Model (2) states that, given responses from all other subjects and covariatesXi, the conditional
distribution of Yi is normal with mean β
TXi + γ
∑
j 6=i s(Gi,Gj)(Yj −β
TXTj ) and variance ζ
2. We
construct the pseudo-likelihood according to Besag (1975) as
Lpd =
n∏
i=1
{
1√
2piζ2
exp
[
−
1
2ζ2
{
Yi − β
TXi − γ
∑
j 6=i
s(Gi,Gj)(Yj − β
TXj)
}2]}
,
which is a product of the conditional densities of Yi across i. Also according to Besag (1975), assuming
β is known, one may estimate γ by the maximum pseudo-likelihood method. The estimator for γ
can be obtained by minimizing
∑n
i=1
{
Yi−β
TXi−γ
∑
j 6=i s(Gi,Gj)(Yj−β
TXj
}2
, which in matrix
notation is equal to
{(I − γS)(Y −Xβ)}T (I − γS)(Y −Xβ).
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The minimization leads to an estimator for γ given by
⇒ γ˜ =
(Y −Xβ)TS(Y −Xβ)
(Y −Xβ)TS2(Y −Xβ)
. (5)
Intuitively one expects that a large value of γ˜ would give us evidence to reject the null hypothesis
that γ = 0. In practice, β in unknown. We propose to replace β by its least square estimator β̂
under the null hypothesis, i.e., β̂ = (XTX)−1XTY which is unbiased for β. Substitute β̂ into the
expression for γ˜ and straightforward algebra leads to the final test statistic:
γ̂ =
Y TBSBY
Y TBS2BY
, (6)
whereB = I−X(XTX)−1XT . Again a large value of γ̂ supports the rejection of the null hypothesis.
We next show how the p-value for testing γ = 0 can be obtained based on the test statistic γ̂;
i.e., we would like to calculate the probability of γ̂ greater than the observed value of the statistic
under the null hypothesis. Suppose η is the observed value of the test statistic γ̂. Since BS2B is
positive-definite, we have
PH0
(
Y TBSBY
Y TBS2BY
> η
)
= PH0
(
(BY )T (S − ηS2)BY > 0
)
As it is assumed that εi ∼ N(0, ζ
2), i.i.d. across i, it follows that BY ∼ N(0, ζ2B2) under the null
hypothesis. On the other hand, the statistic γ̂ in (6) is ancillary to ζ2 because ζ2 in the numerator
and denominator cancels out. Therefore, the above equation becomes
PH0
(
(BY )T (S − ηS2)BY > 0
)
= P
(
ZT (S − ηS2)Z > 0
)
,
where Z is an n×1 random vector following N(0,B2). Applying standard results on the distribution
of quadratic form in normal random variables, we have
ZT (S − ηS2)Z ∼
n∑
i
λiΦi,
where Φi’s are i.i.d random variables with χ
2
1 distribution, and {λi} are the eigenvalues of B(S −
ηS2)B. The final p-value can be obtained by Davies’ exact method (1980) for the weighted summa-
tion of independent Chi-square variables.
The proposed test has several appealing properties. First, due to the analytical form of the
test statistic, the computational burden is well controlled. Second, as γ̂ in (6) is ancillary to ζ2,
unlike SKAT, there is no need to plug in a consistent estimator for ζ2. Third, the proposed method
improves power by exploiting LD and allowing for possible complex interactions among variants.
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Linkage disequilibrium can cause correlations between variants, especially when we consider nearby
loci. Considering similarity in variants can naturally reduce the degree of freedom. In the extreme
case where components of Gi are “perfectly correlated”, the similarity argument will consider the
whole set as a single variable. In addition, genetic variants involved in the disease pathway are
more likely to interact with each other than contribute to risk individually, known as the epistatic
variants effect. Specifying two-way interactions in a set of loci is a challenging high-dimensional
problem and the situation gets even worse in modeling higher order interactions. Since GenRF does
not directly model the relationship of Gi with Yi, the difficulty of modeling complex interactions
are circumvented and the interaction effect is naturally incorporated through measuring genetic
similarity. Finally, as SKAT, the GenRF test can boost power of testing rare variants by increasing
their weights by specifying wk appropriately for variant k.
2.3. Robustness to Other Distributions
The derivation of the GenRF test given above is built on the normal distribution assumption. Asymp-
totically, the proposed test is robust to distributions other than normal with slight modification. Con-
sider PH0
(
(BY )T (S − ηS2)BY > 0
)
, where it is now assumed Y follows an arbitrary distribution
with mean zero and possibly heteroscadastic variances. The random quantity (BY )T (S − ηS2)BY
is a quadratic form in BY (with mean 0) with matrix A = S − ηS2. Rotar (1974) proved that
under sufficiently weak conditions on matrix A and for large n, PH0
(
(BY )T (S − ηS2)BY > 0
)
is
close to PH0(Z˜
T
(S − ηS2)Z˜ > 0), where Z˜ follows N(0,Σ) with Σ being the covariance matrix of
BY . In addition, Gotze and Tikhomirov (1999) gave an upper bound on supx
∣∣PH0((BY )TABY <
x
)
− PH0 (Z˜
T
AZ˜ < x)
∣∣. These properties lead to the robustness of the GenRF test, with minor
modification, as long as BY has expectation zero under the null hypothesis, which is true since the
least squares estimator X(XTX)−1XTY is unbiased for the mean of Y regardless of the distribu-
tion of Y . For example, for binary traits, Σ = BWB, whereW = diag(µ1(1−µ1), . . . , µn(1−µn))
and µi = β
TXi. Then
Z˜
T
(S − ηS2)Z˜ ∼
n∑
i
λ˜iΦi,
where Φi’s are i.i.d random variables with χ
2
1 distribution, and {λ˜i} are the eigenvalues ofW
1
2B(S−
ηS2)BW
1
2 . The final p-value can be also obtained by Davies’ exact method (1980). We comment
that, as the score test in SKAT is of similar quadratic form, one would expect that SKAT may share
this property as well.
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Therefore, one can directly use the test statistic in (6) for binary traits or traits that have distribu-
tions other than normal and the test, with a minor modification on the null distribution considering
heteroscedastic variances, would be asymptotically valid. Note, this test corresponds to a model
where the trait mean is related to a linear predictor through an identity link and may seem unnat-
ural for binary traits. However, we argue that the model is mostly viewed as a mean leading to a
sensible test. We also note that the commonly used trend test for testing genetic associations in an
additive genetic model can be developed from a linear model for the mean of a binary trait (Laird
and Lange, 2011), and a linear model is used for testing genetic associations for a binary trait in
Ballard, et al. (2010) as well. We note that a possible practical issue for binary traits may arise in
practice, i.e., the estimated means {µ̂i} may be outside of [0,1] and consequently Ŵ
1
2
is not well
defined. In this case, a remedy is to truncate the predictions {µ̂i} at 0 or 1. The practical issue
may arise when covariates have a wide support and a very strong effect and is less of a concern
otherwise, for example, when covariates are categorical. Certainly, studying other link functions,
e.g., the logit link, to avoid this practical problem is important in the future. The validity of the
test, corresponding to an identity link, is further studied by simulations shown in sections 1 and 2
of the supplemental materials.
3. Simulation Studies
We report results of several simulations, each based on 1000 Monte Carlo (MC) replicates, to evaluate
the performance of the GenRF test, relative to existing methods including SKAT. Four sets of
simulations are conducted to evaluate 1) type-1 error rates under different minor allele frequencies
(MAF) and sample sizes, 2) power for common variant analysis under different LD, interaction
effect, and proportions of causal SNPs, 3) power under scenarios where the causal SNPs include rare
variants, and 4) robustness of the GenRF test to different distributions of the response variable.
In the first set of simulations, we evaluated type-I error rates using sample size n = 50, 100, 200
and 500 . Genotypes for p = 20 loci without LD were simulated, with MAF for each locus 0.005,
0.01, 0.1, or 0.2. Responses were generated according to
Yi = εi, where εi ∼ N(0, 1),
so that no genetic variant is associated with the trait.
In the second set of simulations, we evaluated power under scenarios varying in LD, interaction
effects, or the proportions of causal SNPs, setting p = 20 and n = 500. To simulate LD, the 20 loci
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were evenly divided into two regions. For each region, the haplotype allele was simulated one by one
with MAF 0.2 and correlation coefficient (ρ) between adjacent pair of alleles equal to 0, 0.2, 0.4,
0.8 respectively for each scenario. Genotypes were then generated by summing up two haplotype
vectors. This way, all the loci are positively correlated with others in the same region. Responses
were generated according to
Yi = 0.2Gi,5 + 0.2Gi,15 + εi, where εi ∼ N(0, 1).
That is, variants 5 and 15, belonging to different LD regions, are associated with the trait.
To generate data with complex interactions, we set MAF 0.2, and the LD parameter ρ = 0.4. Data
were generated such that two-way interactions exist between K (K = 1, 2, 3 or 4) pairs of alleles,
with alleles in each pair belonging to the two different LD regions as described above. Responses
were then generated according to the following model,
Yi = 0.2
K∑
k=1
Gi,4+kGi,14+k + εi, where εi ∼ N(0, 1). (7)
We see that these models contain only interactions but no main effect of each locus.
To examine the effect of causal proportion, we set MAF 0.2 and ρ = 0.4. For each MC data set,
K causal SNPs were randomly selected with K = 1, 2, 3, or 4, each corresponding to 5%, 10%, 15%
and 20% causal SNPs. Responses were then generated according to
Yi = 0.15
K∑
k=1
Gi,Bk + εi, where εi ∼ N(0, 1), (8)
where (GB1 , . . . , GBK ) are the selected causal SNPs.
Simulation set 2 has focused on common variants. The third set of simulations considered scenarios
involving rare variants and the scenarios vary in proportions of causal variants. We set p = 20,
n = 500, and ρ = 0. The 20 SNPs were divided into two regions, one with 16 rare variants (MAF
0.008) and one with 4 common variants (MAF 0.1). Note, the proportion of rare variants is chosen
according to the Dallas Heart Study . Two scenarios were considered where traits were associated
with: 1) rare variants only or 2) both common and rare variants. For each scenario, K rare SNPs
were causal with K = 1, 2, 4, 6, 8, 10, 12 or 14, i.e., K×6.25% SNPs in the rare region are causal. In
the scenario that both rare and common variants are causal, we set one of the common SNP as causal
additionally. The effect size β was set to be a decreasing function of MAF with β = 0.2×| log10MAF|
as in Wu et al. (2011). Responses were generated according to the following model,
Yi = β1
K∑
k=1
Gi,k + β2Gi,20 + εi, where εi ∼ N(0, 1),
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where β1 = 0.2×| log10 0.008|, β2 = 0 for scenario 1 and β1 = 0.2×| log10 0.008|, β2 = 0.2×| log10 0.1|
for scenario 2.
We considered one additional scenario where the 500 subjects’ genotypes were simulated based
on data from the Dallas Heart Study. For each MC data set, we randomly selected one gene, then
we randomly choose 10%, 20%, . . . , 80% causal variants from those rare variants with true MAF less
than 1%. Traits were simulated by
Yi =
K∑
k=1
βBkGi,Bk + εi, where εi ∼ N(0, 1),
where (GB1 , . . . , GBK ) are the selected causal variants and βBk = 0.2× | log10MAFBk |.
In the fourth set of simulations, we further evaluated the robustness of the GenRF test to distribu-
tions other than normal, specifically, exponential, binary and mixture normal distributions. Details
on the simulation setup is described in the supplemental materials.
In terms of type-I error rates, we only evaluated the proposed GenRF test and SKAT. In both
GenRF and SKAT, we adopted the IBS kernel and considered both weighted and unweighted (i.e.,
wk = 1) versions; in the weighted version, Beta (1, 25) weight as in Wu, et al. was used (2011). In
addition to SKAT, we compared GenRF test to other more standard methods. For common variant
scenarios, we included the principle component regression test (PCR) (Guaderman et al., 2007); the
MinSNP test (Ballard et al., 2010) and the F-test in linear regression model including only main
effects. For scenarios involving rare variants, the variable-threshold (VT) test (Price et al., 2010)
was included.
Table 1 shows results for the first set of simulations with different MAF and sample sizes. The
GenRF test achieves the type I error rate close to the nominal level. However, SKAT is conservative
in some scenarios due to the estimation of nuisance parameters, especially when the sample size
is small. Since the GenRF test is an exact test without asymptotic approximation under normal
assumption, the type I error rate is better controlled.
Table 2 shows the power of various methods under common variant scenarios. The first part
shows the effect of LD on power. When LD does not exist or is low, e.g., ρ < 0.4, the three linear
regression based tests, PCR, MinSNP and F-test , are more powerful as expected because the data
were generated exactly from a linear model. Among them, the PCR and MinSNP can exploit LD and
have increasing power when LD is higher. When LD is moderate or high, both the GenRF test and
SKAT have higher or even substantially higher power than the other tests by borrowing information
from other loci. The power of the GenRF test is comparable to that of SKAT.
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The second part shows results when there are complex interactions between variants but no main
effects. Note the LD structure is the same as that in part 1 with ρ = 0.4 in which the five methods
have comparable power. Therefore, the power difference is mainly due to the complex interactions. In
these scenarios, the linear regression based methods has low power in detecting the joint association.
Both GenRF test and SKAT attain much larger power. Moreover, the proposed GenRF test has
larger power than SKAT in detecting the joint association effect when complex interactions exist.
The third part shows results when the causal proportion varies. Similarly, the LD parameter ρ is
set to be 0.4 to eliminate the impact of factors other than the causal proportion. Because MinSNP
is based on single SNP analysis, the test is less powerful especially when causal proportion is high,
i.e. 15% or 20%. GenRF and SKAT show comparable power in general, but GenRF performs better
as causal proportion gets higher.
Table 3 shows results for scenarios involving rare variants . When the trait is only associated
with rare variants, the weighted GenRF and SKAT have significantly larger power as we expected
because the weights favor the rare variants. The weighted GenRF has lower power than SKAT when
the causal proportion is low, e.g., ≤ 25%, but has larger power then the proportion is greater than
25%. Both weighted GenRF and SKAT have comparable or larger power relative to the VT test and
F-test. The scenario based on the Dallas Heart Study shows similar results, i.e. GenRF performs
better under higher causal proportion (≥ 20%).
When causal variants include both common and rare variants and the effect size is a decreasing
function of MAF, the unweighted GenRF and SKAT have comparably larger power than the weighted
tests when the rare causal proportion is low (≤ 37.5%). This is not surprising as the effect of the
common variant is relatively large but down-weighted in the weighted GenRF and SKAT. As the
rare causal proportion increases and the number of common variants is fixed at one, the results
change dramatically. When the rare causal proportion is higher than 37.5%, the weighted GenRF
and SKAT show higher power than the unweighted counterpart. Overall, for scenarios considered
here, the GenRF test has very good performance relative to others.
Supplementary Tables 1 and 2 show the robustness of the GenRF test to distributions other than
normal. In implementing GenRF and SKAT, the identity link is used in modeling the responses.
The GenRF test achieves the type I error rate close to the nominal level even when the distribution
of the response is not normal; the same holds for SKAT. Particularly, for binary traits, we evaluated
the robustness of the GenRF test to heteroscedastic variances in Section 2 of the supplementary
materials. Valid type I error rates and reasonably good power are achieved. In addition, the remedy
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Table 1
Type I error rate simulation results under different levels of MAF and sample size (1000 replicates). Each cell
contains the type I error rate, i.e., rejection rate when data are generated under the null model. GenRF: the
unweighted genetic random field test; SKAT: the unweighted sequential kernel association test of Wu, et al. (2011);
GenRF.w: GenRF with Beta(1,25) weight as in Wu, et al. (2011); SKAT.w: SKAT with Beta(1,25) weight.
Methods Different Levels of MAF and Sample Size (n)
MAF 0.005 0.01
n 50 100 200 500 50 100 200 500
GenRF 0.043 0.049 0.050 0.045 0.040 0.043 0.061 0.048
GenRF.w 0.048 0.056 0.051 0.045 0.043 0.046 0.060 0.046
SKAT 0.035 0.051 0.057 0.057 0.034 0.046 0.050 0.039
SKAT.w 0.034 0.050 0.053 0.059 0.029 0.042 0.046 0.035
MAF 0.1 0.2
n 50 100 200 500 50 100 200 500
GenRF 0.051 0.049 0.055 0.044 0.050 0.058 0.055 0.049
GenRF.w 0.052 0.052 0.053 0.048 0.047 0.051 0.052 0.046
SKAT 0.022 0.039 0.041 0.041 0.016 0.030 0.041 0.043
SKAT.w 0.041 0.035 0.043 0.054 0.045 0.043 0.046 0.041
by truncation when predictions fall outside of the range of [0,1] works well in practice, even under
extreme and possibly unrealistic scenarios.
4. Application
We applied our method to the Dallas Heart Study (Browning et al., 2004), a population-based, multi-
ethnic study on 3551 subjects whose Lipids and glucose metabolism were measured. In this study,
348 sequence variations in the coding regions of the four genes, ANGPTL3, ANGPTL4, ANGPTL5
and ANGPTL6 were discovered. Most of these variants (86%) are rare with MAF less than 1%.
More information regarding the number of rare variants is shown in the Supplementary Materials.
Individuals who have diabetes mellitus, alcohol dependency or have taken lipids lowering drugs were
excluded as these factors may confound the interpretation of associations. Our final analysis was
based on data on 2812 subjects after quality control steps.
We assessed the association between ANGPTL gene families and two traits, specifically high-
density lipoprotein (HDL) and triglyceride, using the proposed GenRF test and SKAT, both with
and without weighting. As in the simulation studies, the IBS kernel and the Beta (1, 25) weight were
applied. Analyses were also carried out using the more traditional methods including PCR, MinSNP,
VT and F-test. Our analysis were done for the non-synonymous variants, adjusted for gender and
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Table 2
Power simulation results for common variant analysis under different levels of linkage disequilibrium (LD),
interaction effects and causal proportion (1000 replicates). GenRF: the unweighted genetic random field test;
SKAT: the unweighted sequential kernel association test of Wu, et al. (2011); PCR: the princeple component
regression test of Guaderman et al. (2007); MinSNP: the MinSNP test considered by Ballard et al. (2010); F-test:
the F-test in linear regression.
Method Different Level of LD Number of Two-way Interactions Different Causal Proportion
0 0.2 0.4 0.8 1 2 3 4 5% 10% 15% 20%
GenRF 0.462 0.472 0.566 0.816 0.119 0.364 0.652 0.862 0.124 0.321 0.539 0.776
SKAT 0.491 0.487 0.545 0.764 0.100 0.299 0.546 0.746 0.150 0.324 0.506 0.727
PCR 0.495 0.467 0.518 0.676 0.119 0.268 0.470 0.657 0.159 0.308 0.473 0.679
MinSNP 0.570 0.507 0.543 0.656 0.098 0.252 0.408 0.576 0.180 0.342 0.463 0.624
F-test 0.545 0.514 0.524 0.538 0.112 0.231 0.394 0.562 0.145 0.278 0.471 0.665
ethnicity.
The association between ANGPTL4 gene and the level of HDL and triglyceride was previously
discovered by Romeo, et al. (2007). In our analysis, both weighted GenRF and SKAT gave evidence
for the ANGPTL4 and triglyceride association (p-values: 0.019 and 0.006). Among all the methods
considered, only weighted SKAT showed marginal evidence for the association between ANGPTL4
and HDL (p-value: 0.040). One possible explanation is that the causal proportion of ANGPTL4 is low
and SKAT performs better in this case as shown in simulation studies. Note that the weighted GenRF
and SKAT uncovered these associations while the unweighted tests did not, possibly indicating the
causal variants in ANGPTL4 might be rare (MAF < 5%), or the effect size is negatively correlated
with allele frequency. As for ANGPTL5, our analysis using GenRF provided evidence to support
the association with HDL (p-value: 0.009 and 0.036 for weighted and unweighted analyses) while
SKAT provided marginal evidence (p-value: 0.035 and 0.050). Note the unweighted tests gave larger
p-values. Since all variants in ANGPTL5 are rare (MAF < 5%), the result suggests that the causal
variants might be the rare variants with relatively higher allele frequency. This finding was supported
by standard approaches like MinSNP (p-value: 0.033), F-test (p-value: 0.051) and VT test (p-value:
0.051). More results are shown in table 4. Overall, for this study, GenRF performs comparably to
SKAT and seems to perform better than the other more standard methods.
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Table 3
Power simulation results under scenarios involving rare variants with different proportion of causal variants (1000
replicates). Rare Causal Variants: causal variants are rare only; Common & Rare Causal Variants: causal variants
are both rare and common; DHS: scenario based on the Dallas Heart Study. GenRF.w: the genetic random field test
with Beta (1, 25) weight as in Wu, et al. (2011); SKAT.w: the sequential kernel association test with Beta (1, 25)
weight; VT: the variable-threshold test of Price et al. (2010); Other entries as in Table 2.
Method Different Proportion of Causal Variants
Rare Causal Variants
6.25% 12.5% 25% 37.5% 50% 62.5% 75% 87.5%
GenRF 0.045 0.073 0.139 0.209 0.305 0.466 0.593 0.739
SKAT 0.048 0.052 0.066 0.073 0.086 0.100 0.111 0.126
GenRF.w 0.062 0.087 0.212 0.429 0.660 0.848 0.950 0.980
SKAT.w 0.083 0.125 0.252 0.368 0.515 0.654 0.736 0.814
VT 0.065 0.082 0.128 0.209 0.314 0.487 0.680 0.852
F-test 0.080 0.113 0.190 0.302 0.449 0.556 0.670 0.765
Common & Rare Causal Variants
6.25% 12.5% 25% 37.5% 50% 62.5% 75% 87.5%
GenRF 0.191 0.259 0.380 0.501 0.625 0.761 0.861 0.927
SKAT 0.274 0.281 0.287 0.313 0.331 0.359 0.387 0.416
GenRF.w 0.061 0.097 0.232 0.434 0.646 0.853 0.939 0.981
SKAT.w 0.078 0.155 0.277 0.386 0.523 0.631 0.732 0.818
VT 0.217 0.306 0.418 0.504 0.603 0.720 0.845 0.930
F-test 0.163 0.270 0.354 0.477 0.618 0.701 0.779 0.843
DHS
10% 20% 30% 40% 50% 60% 70% 80%
GenRF 0.080 0.140 0.169 0.247 0.329 0.414 0.507 0.600
SKAT 0.071 0.089 0.114 0.117 0.153 0.191 0.205 0.271
GenRF.w 0.100 0.204 0.321 0.434 0.588 0.696 0.796 0.875
SKAT.w 0.118 0.196 0.294 0.330 0.433 0.544 0.600 0.688
VT 0.095 0.159 0.254 0.359 0.498 0.612 0.721 0.827
F-test 0.147 0.239 0.355 0.423 0.528 0.653 0.721 0.795
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Table 4
Application to Dallas Heart Study for non-synonymous variants. GenRF: the unweighted genetic random field test;
SKAT: the unweighted sequential kernel association test of Wu, et al. (2011); PCR: the princeple component
regression test of Guaderman et al. (2007); MinSNP: the MinSNP test considered by Ballard et al. (2010); F-test:
the F-test in linear regression; GenRF.w: the genetic random field test with Beta (1, 25) weight of Wu, et al.
(2011); SKAT.w: the sequential kernel association test with Beta (1, 25) weight; VT: the variable-threshold test of
Price et al. (2010). ∗ indicates p-value is less than or equal to α = 0.05.
Method P-value
HDL
ANGPTL3 ANGPTL4 ANGPTL5 ANGPTL6
GenRF 0.487 0.181 0.009∗ 0.417
SKAT 0.981 0.423 0.035∗ 0.504
PCR 0.980 0.775 0.197 0.434
MinSNP 0.178 0.329 0.033∗ 0.729
F-test 0.331 0.148 0.051 0.786
GenRF.w 0.345 0.218 0.036∗ 0.496
SKAT.w 0.965 0.040∗ 0.050∗ 0.535
VT 0.393 0.111 0.051 0.488
Triglyceride
ANGPTL3 ANGPTL4 ANGPTL5 ANGPTL6
GenRF 0.025∗ 0.221 0.428 0.857
SKAT 0.050∗ 0.312 0.936 0.755
PCR 0.129 0.780 0.787 0.762
MinSNP 0.562 0.219 0.921 0.713
F-test 0.587 0.380 0.904 0.530
GenRF.w 0.100 0.019∗ 0.180 0.466
SKAT.w 0.075 0.006∗ 0.906 0.756
VT 0.993 0.905 0.968 0.050∗
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5. Discussion
We have proposed a novel framework for modeling and testing for the joint association of genetic
variants with a trait from the perspective of viewing traits as a random field on a genetic space. The
development has been focused on quantitative traits with a normal distribution. Based on the GenRF
model, a test for genetic associations was developed and this test enjoys many appealing features.
The GenRF test is based on testing a null hypothesis involving a single parameter, allowing it to
exploit LD to improve power. When LD is moderate or high, our simulations showed that the GenRF
test achieves much higher power than the more traditional regression-based methods. The GenRF
model is flexible to allow for complex interaction effects and, as demonstrated by simulations, the
GenRF test is even much more powerful than SKAT in the presence of complex interaction effects.
Moreover, as SKAT, prespecified variant-specific weights can be incorporated to boost power for rare
variants. Unlike SKAT, the GenRF test is an exact test under the normal assumption and thus not
overly conservative in finite samples. Finally, the test is computationally easy to implement since
an analytical form is available. In summary, the GenRF test is an appealing alternative to SKAT
and other existing methods for testing the joint association of variants with a trait. It can achieve
overall comparable performance and sometimes even much better performance relative to SKAT as
well as other methods.
Although we focus on quantitative traits, we note that the GenRF test is robust to distributions
other than normal as discussed previously and demonstrated by simulation studies. Specifically for
binary traits, although the GenRF model with an identity link function may seem a bit unnatural,
the resulting test with a minor modification is still valid and can achieve good power. However,
due to the conceptual difficulty associated with modeling binary traits using a linear model and
the possible practical issue that can arise, it would be interesting to study, within the framework of
random field model, other link functions for binary traits as well as other distributions in the future.
6. Supplementary Materials
6.1. Robustness to other distributions
We evaluated the robustness of the GenRF test to distributions other than normal. The GenRF test
for traits with distributions other than normal is described in Section 2.3 of the main manuscript.
The simulation setup is otherwise similar to the first set of simulations, described in Section 3 of the
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main manuscript, with only one region, p = 10, ρ = 0.4 and n = 100. Responses Yi were generated
according to generalized linear models using the canonical link function, i.e.,
g(µi) = aGi,5,
where a was set to be 1.1 and 2.5 respectively for exponential and binary distributions. For Mixture
Normal, we generated two normal distributions with mean difference 10, equal mixture propor-
tions, and a = 2.7. We set a to be 0 in evaluating the type-I error rate. The results are shown in
Supplementary Table 5.
Supplementary Table 5
Simulation results under different distributions of the response variable (1000 replicates). ∗ indicates results are
unavailable due to “sample size is small, need small sample adjustment” and SKAT has no small sample
adjustment for IBS kernel.
Method Distribution
Exponential Mixture Normal Binary
GenRF Power 0.636 0.582 0.646
Type I 0.052 0.056 0.046
SKAT Power 0.655 0.582 ∗
Type I 0.046 0.046 ∗
F-test Power 0.572 0.568 0.559
Type I 0.056 0.054 0.050
6.2. Robustness to heteroscedastic variances of binary traits
We evaluated the robustness of the GenRF test to heteroscedasitc variances of binary traits. Since
the variance of a binary outcome is a function of its mean, the variance is known to be heteroscedastic
when the mean of outcome depends on covariates. The modification of the GenRF test for binary
traits is described in Section 2.3 of the main manuscript. The simulation setup is otherwise similar
to the first set of simulations, described in Section 3 of the main manuscript, with p = 20, ρ = 0,
minor allele frequency 0.2, and n = 100. Responses Yi were generated according to logistic models,
i.e.,
logit(pi) = aGi,5 + bXi,
where a was set to be 3 in evaluating power and 0 in evaluating type I error rate; Xi was a covariate
generated from N(0, 1); and b was varying from 0 to 10 to generate different levels of heteroscedastic
variance. A larger coefficient b results in a wider range of the predicted mean and thus more het-
eroscedastic variance. When b = 5 or 10, which represents unusually strong effect of X (probably
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unlikely in practice), some predicted means fall outside of [0, 1] and truncation at 0 or 1 was used.
The results are shown in Supplementary Table 6. We note that the power decreases as the coefficient
b increases because the noise becomes larger. The type I error is well controlled even if some pre-
dicted means reached 0 or 1, indicating that the GenRF test with the minor modification is robust
to heteroscedastic variances of binary traits.
Supplementary Table 6
Simulation results under different levels of heteroscedastic variances (500 replicates). Coefficient: the coefficient of
the covariate. ∗ indicates that some predicted means reached 0 or 1.
Method Coefficient
0 1 3 5∗ 10∗
GenRF Power 0.538 0.594 0.408 0.290 0.110
Type I 0.052 0.046 0.040 0.058 0.060
6.3. Application to Dallas Heart Study
We analyzed data from the Dallas Heart Study (Browning et al., 2004.), a population-based, multi-
ethnic study on 3551 subjects whose lipids and glucose metabolism are measured. In this study,
sequence variations in the coding regions of the four genes, ANGPTL3, ANGPTL4, ANGPTL5 and
ANGPTL6 are discovered. Supplementary Table 7 lists the number of non-synonymous variants in
each gene and their MAFs.
Supplementary Table 7
Dallas Heart Study sequencing data information: number of non-synonymous variants in each gene. MAF: minor
allele frequency.
Number of Variants
ANGPTL3 ANGPTL4 ANGPTL5 ANGPTL6
All 21 25 18 25
MAF < 5% 21 24 18 25
MAF < 1% 20 23 17 24
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